New Delhi, June 8 -- The shortage of platinum-based cancer drugs like Cisplatin and Carboplatin is a threat to cancer care treatment, the top Experts from AIIMS Delhi stated, as these drugs play a crucial role in the treatment of cancer like head and neck, lung, ovarian, bladder, and gastrointestinal cancers.

"As a surgical oncologist at AIIMS Delhi, I view the reported shortage of cisplatin and carboplatin as a critical threat to cancer care. These platinum-based agents are backbone drugs in treating common malignancies--head and neck, lung, ovarian, bladder, and gastrointestinal cancers. In my practice, I frequently integrate them with surgery as HIPEC and in multimodal protocols; their absence compromises neoadjuvant and adjuvant stra...